MDS research criteria for prodromal Parkinson's disease
Dr. Reddy's Laboratories (United States) · German Center for Neurodegenerative Diseases · +22 more institutions
Abstract
This article describes research criteria and probability methodology for the diagnosis of prodromal PD. Prodromal disease refers to the stage wherein early symptoms or signs of PD neurodegeneration are present, but classic clinical diagnosis based on fully evolved motor parkinsonism is not yet possible. Given the lack of clear neuroprotective/disease-modifying therapy for prodromal PD, these criteria were developed for research purposes only. The criteria are based upon the likelihood of prodromal disease being present with probable prodromal PD defined as ≥80% certainty. Certainty estimates rely upon calculation of an individual's risk of having prodromal PD, using a Bayesian naïve classifier. In this…
Citation impact
- FWCI
- 69.01
- Percentile
- 100%
- References
- 63
Authors
20- DBDaniela BergCorresponding
Dr. Reddy's Laboratories (United States), German Center for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research
- RBRonald B. Postuma
Dr. Reddy's Laboratories (United States), Montreal General Hospital
- CHCharles H. Adler
Mayo Clinic in Arizona
- BRBastiaan R. Bloem
Radboud University Nijmegen, Radboud University Medical Center
- PCPiu Chan
Capital Medical University, Xuan Wu Hospital of the Capital Medical University
Topics & keywords
- Prodromal Stage
- Parkinsonism
- Disease
- Parkinson's disease
- Psychology
- Medicine
- Dementia
- Pathology